V2X Heads to Jefferies With a Backlog Story the Cash Hasn't Confirmed

"V2X to Participate in the 2026 Jefferies Global Industrials Conference." Read as a headline, that sounds like news. Read as an investor, it is an appointment: on Thursday, September 10 at 12:10 p.m. Eastern, V2X's management will take its scheduled slot at the conference, and anyone who misses it can catch the webcast replay for 90 days afterward. Conferences are where companies go to tell their story to investors, not where stories get made. So the useful question is what V2X carries into that room, and whether a defense-services story whose shares have already risen about 41% this year has numbers behind the telling.

What this company actually is

V2X is not the vehicle-to-everything technology the acronym suggests. It is the Reston, Virginia contractor formed in July 2022 when Vectrus combined with The Vertex Company — roughly 16,000 people doing the unglamorous work that keeps armed forces operational: running bases, sustaining aircraft the Air Force already owns, logistics under the Army's LOGCAP program in Kuwait, training, engineering. It does not build jets. It keeps existing ones flying and the bases they fly from running — closer to a toll road on military readiness than to a weapons platform.

That distinction shapes the economics and should shape expectations. This is a labor-heavy business on thin margins — adjusted EBITDA margin of 7.1% in the second quarter — with effectively one dominant customer, the U.S. government, which sets the prices because most contracts are recompeted every few years. The moat here is not pricing power, which is the first thing I look for in any income story. It is incumbency: a workforce that is already cleared, already on the ground, and already trained is hard to replace, and the friction of moving it is the company's real protection. That is a genuine moat, but a defensive one. And for anyone whose goal is dividend income, the screen ends almost immediately: V2X pays no dividend, so there is no payout to examine and no yield to compound. This is a capital-gains case, full stop.

Why the market noticed

Start with the macro. In April the administration proposed a roughly $1.5 trillion FY2027 defense budget, an increase of roughly $445 billion, or about 40%, over the prior year's funding — the kind of step-up the defense sector has not seen in decades. Hold that number properly. It is a request, not an appropriation, it leans on reconciliation funding that Congress will fight over, and the administration's own projections show defense spending declining by double-digit percentages in real terms the following year. Directional tailwind, contested path.

Then the company layer. V2X reported second-quarter revenue of $1.26 billion, up 17% year over year, and raised its full-year revenue guidance to $4.875 billion to $5.025 billion with adjusted EPS guidance of $5.90 to $6.30. It added contract wins that matter: the $4.3 billion T-6 sustainment contract, work on which it resumed after the U.S. Court of Federal Claims upheld the Air Force's award, and a $500 million C-12 sustainment contract announced in early August. Late in July it was added to the S&P SmallCap 600 index, a mechanical event that brings passive buyers. No single catalyst explains the run; the sum does.

The numbers to listen for

Here is where a conference appearance earns its keep, because management will walk investors through the number class that decides this story: backlog, and how it converts. The company reports total backlog of $12.7 billion, but only $2.5 billion of it is funded — meaning money is actually on contract — and about 98% of this year's revenue is already secured in backlog. Stop on that, because it is the whole point in miniature: fiscal 2026 is essentially sold out. Every bit of further upside in the stock is a bet on 2027 and beyond.

So the indicators that matter point forward. Book-to-bill — new business booked relative to revenue recognized, and the leading indicator in this business — was just about 0.5x in the second quarter, though 1.4x over the trailing twelve months. The submitted bid pipeline stands above $8 billion. That pipeline is the future. The existing portfolio is lumpy in the present: management flagged that Kuwait logistics work steps down sharply in the second half of the year, partly offset by ramping activity in Israel.

And then there are the recompetes, the quiet risk under everything. Most of V2X's revenue is eventually re-bid, and management has described the current period as a "recompete holiday" — a window when few large contracts are being retendered, so capital goes into new bids instead of defending old ones. That holiday ends. Losing a single large recompete removes a block of revenue, and there is no dividend to hold you while the outcome plays out.

The cash test

The second-layer discipline is worth filing away as a general lesson: adjusted earnings growth is a partial picture; cash is the whole picture. V2X guides 2026 adjusted operating cash flow to just $160 million to $180 million against roughly $355 million of adjusted EBITDA — about half the EBITDA survives interest, taxes, and working capital. Trailing free cash flow is thinner still, near $130 million over the last four quarters and down 38% from a year earlier, while net leverage sits around 2.4x toward a year-end target of roughly 2x. Adjusted EPS is an honest number for some purposes; it is not the number that pays the balance sheet.

That gap is exactly where the valuation gets confusing, and the confusion is worth naming. At about $77, the shares go for roughly 12 to 13 times this year's adjusted EPS guidance — by that read, not expensive for a contractor growing revenue in the mid-teens. Quote the same stock on reported GAAP earnings, which carry the accounting for the 2022 merger's amortization, and the trailing multiple is closer to 26 times. Both are real numbers; they measure different earnings. The neighbors add context of their own: Booz Allen, Leidos, and KBR each mail out dividends, while V2X, at 2x leverage and single-digit margins, sends shareholders nothing.

What to do with the webcast

When the September 10 webcast goes live, filter it for three things: whether funded backlog keeps climbing, whether that $8 billion pipeline converts into announced awards, and any hint of when a company with this little cash conversion starts returning money to owners. Do not expect a surprise — conference slots are scheduled marketing, and V2X laid out its full position at the August earnings call.

None of this makes V2X a bad business. It is real, it sits in the sector where government money is clearly pointing, and the growth is genuine. What it is not is an income vehicle, and its share price has already been told the story. The conference will not change the facts; it only lets you test the weakest seam of the story. And the weakest seam is not the backlog headline. It is how much of that headline turns into cash.